Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 277 for:    Panama

Cervical Length Pre-induction as a Tool to Predict Vaginal Birth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02916082
Recruitment Status : Completed
First Posted : September 27, 2016
Last Update Posted : September 27, 2016
Sponsor:
Information provided by (Responsible Party):
Osvaldo A. Reyes T., Saint Thomas Hospital, Panama

Brief Summary:
To evaluate the value of measuring cervical length as a predictor of vaginal birth after induction of labor with prostaglandins in pregnancies with 41 weeks of gestation.

Condition or disease Intervention/treatment
Cervical Length Measurement Pregnancy, Prolonged Procedure: Cervical length measurement

Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.
Study Start Date : November 2015
Actual Primary Completion Date : June 2016
Actual Study Completion Date : August 2016

Group/Cohort Intervention/treatment
Prolonged pregnancy
Pregnancies with 41 weeks or more of gestation determined by a reliable last menstrual period or early fetal ultrasound.
Procedure: Cervical length measurement
Vaginal ultrasound to measure cervical length previous to use of prostaglandins.




Primary Outcome Measures :
  1. Vaginal Birth [ Time Frame: 72 hours ]
    Number of vaginal births obtained after a measure of cervical length below 2,5 cms.


Secondary Outcome Measures :
  1. Induction to delivery time [ Time Frame: 72 hours ]
    Time (hours) between the application of a prostaglandin and termination of pregnancy (vaginal or cesarean).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnancies with a gestational age of 41 weeks or more.
Criteria

Inclusion Criteria:

  • 41 weeks or more of gestational age
  • Cervical length measured by a FMF certified physician

Exclusion Criteria:

  • Any condition that could interfere with a possible vaginal birth (previous cesarean section, hypertensive disorders of pregnancies).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02916082


Locations
Layout table for location information
Panama
Saint Thomas H
Panama, Panama
Sponsors and Collaborators
Saint Thomas Hospital, Panama

Layout table for additonal information
Responsible Party: Osvaldo A. Reyes T., Coordinator of Research, Saint Thomas Hospital, Panama
ClinicalTrials.gov Identifier: NCT02916082     History of Changes
Other Study ID Numbers: 2015-288V2
First Posted: September 27, 2016    Key Record Dates
Last Update Posted: September 27, 2016
Last Verified: September 2016

Keywords provided by Osvaldo A. Reyes T., Saint Thomas Hospital, Panama:
Cervical length
Prolonged pregnancy
Vaginal birth

Additional relevant MeSH terms:
Layout table for MeSH terms
Pregnancy, Prolonged
Pregnancy Complications